FDA advisory panel lifts restrictions on six wellness peptides

The FDA's advisory committee concluded its two-day meeting by voting to remove the existing limits on six widely used health and wellness peptides.

Committee members said the vote overrode earlier concerns raised by FDA staff, who had highlighted the limited safety and efficacy data for the products.

The decision paves the way for the agency to consider further regulatory actions that could allow broader consumer access to these peptide supplements.